INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of INDO US BIOTECH ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of INDO US BIOTECH Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹175.4 Cr | -1.4% | -10.6% | -41.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,653.4 Cr | 1.7% | 5.6% | -22.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,999.6 Cr | 0.2% | 1.4% | -10.6% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,072.4 Cr | -0% | 1.4% | 7.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹949.7 Cr | -4.2% | -5.2% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹553.3 Cr | 1.3% | 8.3% | 17.5% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -1.4% |
-10.6% |
-41.6% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses